Uncategorized
Allegro receives $2 million grant to support phase 2 study of Luminate
Allegro Ophthalmics has been awarded a $2 million grant from the Type 1 Diabetes Program of the Leona M. and Harry B. Helmsley Charitable Trust, according to a press release.The grant will support the company’s phase 2 study of Luminate (ALG-1001) for the treatment of diabetic macular edema.